LIGAND PHARMACEUTICALS INCORPORATED Other Comprehensive Income (Loss), Net of Tax
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Other Comprehensive Income (Loss), Net of Tax of $230.00 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2021-02-24
- LIGAND PHARMACEUTICALS INCORPORATED other comprehensive income (loss), net of tax for the quarter ending 2019-03-31 was $230.00K.
- LIGAND PHARMACEUTICALS INCORPORATED other comprehensive income (loss), net of tax for the quarter ending 2018-09-30 was $87.00K.
- LIGAND PHARMACEUTICALS INCORPORATED other comprehensive income (loss), net of tax for the quarter ending 2018-03-31 was -$110.00K.
- LIGAND PHARMACEUTICALS INCORPORATED other comprehensive income (loss), net of tax for fiscal 2018 was $73.00K.
- LIGAND PHARMACEUTICALS INCORPORATED other comprehensive income (loss), net of tax for fiscal 2017 was -$257.00K.
- LIGAND PHARMACEUTICALS INCORPORATED other comprehensive income (loss), net of tax for fiscal 2016 was -$2.16M.
- LIGAND PHARMACEUTICALS INCORPORATED other comprehensive income (loss), net of tax for fiscal 2015 was -$50.00K, a 102.45% decline from fiscal 2014.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|
| 2019-03-31 | $230.00K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $73.00K 10-K · filed 2021-02-24 | |
| 2018-09-30 | $87.00K 10-Q · filed 2019-11-08 | |
| 2018-03-31 | -$110.00K 10-Q · filed 2019-05-09 | |
| 2017-12-31 | -$257.00K 10-K · filed 2020-02-27 | |
| 2016-12-31 | -$2.16M 10-K · filed 2019-02-28 | |
| 2015-12-31 | -$50.00K 10-K · filed 2018-03-01 | |
| 2014-12-31 | $2.04M 10-K · filed 2017-02-28 |